30
Apr 2026
AI and CRISPR technologies drive proactive health monitoring
JMIR Publications today featured two new stories in its News and Perspectives section, highlighting a shift toward proactive, tech-integrated health monitoring.
Stay Informed!
30
Apr 2026
Study suggests birth weight affects kidney resilience in ultramarathon athletes
A new study is raising questions about whether human endurance has biological limits shaped long before adulthood-possibly beginning at birth.
30
Apr 2026
Antibiotic minocycline shows potential for treating panic disorder symptoms
A study supported by FAPESP shows that small doses of the antibiotic minocycline may help treat panic disorder.
30
Apr 2026
HPV infections continue after age 27, so who is still at risk?
HPV infections in women aged 27+ highlight the need for updated vaccination policies, emphasizing ongoing risk and the importance of preventive healthcare.
30
Apr 2026
Mailed DNA-based test for colorectal cancer screening
The use of mailed FIT-DNA kits in community health centers significantly increases colorectal cancer screening, though follow-up colonoscopy rates remain low.
30
Apr 2026
Baby teeth show when metal exposure may affect brain development
The study identifies critical windows of metal exposure via baby teeth, revealing impacts on brain development and behavior in children and adolescents.
30
Apr 2026
Sapio Sciences brings Claude Cowork to the lab
Sapio Sciences, the AI lab informatics company, today announced that Claude Cowork, Anthropic's agentic AI assistant, is now integrated with the Sapio Platform via Sapio Elain, the AI co-scientist.
30
Apr 2026
DeNovix launches Squid™ Full Range Pipette: A single device covering 1 – 1000 µL
DeNovix Inc. has introduced a new product to their innovative collection of life science devices—the Squid™ Full Range Pipette.
30
Apr 2026
From killers to strategists: CAR T cells enter their multifunctional era
A review of 1,801 registered CAR T clinical trials shows that multifunctional designs now account for 533 trials and 33% of new CAR T products submitted for clinical testing in 2025. The field is shifting toward multitargeted, safety-controlled, cytokine-secreting, and checkpoint-modulating CAR T cells, but manufacturing, regulation, and limited clinical outcome data remain key barriers.
30
Apr 2026
Single-cell sequencing reveals why some CAR-T therapies succeed while others fail
Single-cell RNA sequencing is giving researchers a clearer view of why some CAR-T cells persist, expand, kill tumors effectively, or become exhausted. The review synthesizes 44 clinical scRNA-seq studies involving 500 patients and highlights how exhaustion, memory, cytotoxicity, clonal diversity, and metabolism may shape CAR-T responses.
